Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Agonistas beta2 de acción prolongada versus placebo además de corticosteroides inhalados para niños y adultos con asma crónica

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD005535Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 19 October 2005see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Airways Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Muireann Ni Chroinin

    Correspondence to: Division of Children's Services, Cork University Hospital, Cork, Ireland

    [email protected]

  • Ilana IG Greenstone

    Montreal Children's Hospital, Montreal, Canada

  • Francine Ducharme

    Direction de la Recherche/ Research Centre, CHU Sainte‐Justine, Montreal, Canada

  • Vincent Masse

    Sherbrooke University, St Lambert, Canada

  • A Danish

    Montreal , Canada

Contributions of authors

Muireann Ni Chroinin reviewed the literature searches from 2002‐2004, identified and reviewed the full‐text publication of all citations of potential or potentially eligible RCTs, extracted the methodology and data, entered the description of studies and data entry in RevMan, analysed and interpreted results of the meta‐analysis and wrote the final review.

Dr Ilana Greestone conceived the protocol, requested the literature search, identified and reviewed the full‐text publication of all citations of potential or potentially eligibible RCTs from 1999‐2001, drafted the correspondance to authors and/or the pharmaceutical companies to solicit their collaboration in this review and to identify other possibly relevant trials, participated in extraction of the methodology and data, entering the description of studies and data entry in RevMan, interpreted results of the meta‐analysis and approved the final review.

Three research assistants participated in some aspects of the review. Helen Magdalinos (May‐July 2001), Alya Danish (November 2001‐March 2002), Vincent Masse (June‐August 2004) participated in the entry of data, references, characteristics of included and excluded studies, and revision of the table of comparisons. Xu Zhang performed and assisted in the interpretation of the meta‐regression.

Francine Ducharme supervised Muireann Ni Chroinin, Ilana Greenstone and the research assistants. She revised the protocol, supervised the literature search, created the methodology and data extraction forms, reviewed all full‐text publications for relevance, participated in the selection of trials, methodology assessment, and data extraction, corresponded with authors and/or the pharmaceutical companies to identify other possibly relevant trials, verify methodology and data extraction and request additional information, supervised the analysis, interpretation, and writing up of the review.

Sources of support

Internal sources

  • Canadian Cochrane Network, McGill University, Canada.

External sources

  • Francine Ducharme was supported by a National Scientist Award from the Fonds de la Santé du Québec, Canada.

Declaraciones de interés

available in

En los cinco últimos años, Francine Ducharme recibió alguna financiación de investigación de Glaxo Wellcome y Astra Zeneca y dio conferencias CME apoyadas por Merck Frost. M Ni Chroinin, IR Greenstone, A, Danish, H Magalinos, V Masse y X Zhang no informaron conflictos de intereses.

Agradecimientos

available in

Se agradece al Grupo Cochrane de Vías Respiratorias (Cochrane Airways Group), en nombre de Stephen Milan, Toby Lasserson, Karen Blackhall, Liz Arnold, Veronica Stewart y Bettina Reuben por las búsquedas de la literatura y el constante apoyo y a Christopher Cates, Peter Gibson y Paul Jones por sus apreciables comentarios. Se agradece a los siguientes autores o patrocinadores correspondientes, a saber G Boyd, X Li, A Tal, E Simons, F Price, JP Kemp, RA Pauwels, G Russell, Van der Molen y AAPH Verberne, así como a Shailesh Patel, Karen Richardson y Rob Pearson de GlaxoSmithKline, Nils Grundstrom y Roger Metcalf de AstraZeneca que cooperaron con entusiasmo a las solicitudes de información y confirmación de la metodología y los datos.

Version history

Published

Title

Stage

Authors

Version

2010 May 12

Addition of long‐acting beta2‐agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children

Review

Francine M Ducharme, Muireann Ni Chroinin, Ilana Greenstone, Toby J Lasserson

https://doi.org/10.1002/14651858.CD005535.pub2

2005 Oct 19

Long‐acting beta2‐agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma

Review

Muireann Ni Chroinin, Ilana IG Greenstone, Francine Ducharme, Vincent Masse, A Danish

https://doi.org/10.1002/14651858.CD005535

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.